Annovis Bio, Inc. (FRA:07X)
Germany · Delayed Price · Currency is EUR 4.610
+0.390 (9.24%)
At close: Nov 28, 2025
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of €102.82 million as of December 1, 2025. Its market cap has increased by 6.35% in one year.
Market Cap
102.82M
Enterprise Value
89.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.61
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from 56.82M to 102.82M, an increase of 80.95%. That is a compound annual growth rate of 10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 102.82M | 53.38% |
| Dec 31, 2024 | 67.03M | -61.39% |
| Dec 29, 2023 | 173.62M | 69.23% |
| Dec 30, 2022 | 102.59M | -18.07% |
| Dec 31, 2021 | 125.22M | 194.78% |
| Dec 31, 2020 | 42.48M | -25.24% |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |